These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28448098)

  • 1. A Monocentric Retrospective Cohort of Patients with Severe Atopic Dermatitis Treated with Cyclosporine A in Daily Practice.
    Daguzé J; Aubert H; Bernier C; Gaultier A; Nguyen JM; Stalder JF; Barbarot S
    Acta Derm Venereol; 2017 Aug; 97(8):955-956. PubMed ID: 28448098
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudotumor cerebri associated with cyclosporine use in severe atopic dermatitis.
    Blasco Morente G; Tercedor Sánchez J; Garrido Colmenero C; Martínez García E; Molina-Carballo A
    Pediatr Dermatol; 2015; 32(2):237-9. PubMed ID: 24330027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index.
    Ariëns LFM; Gadkari A; van Os-Medendorp H; Ayyagari R; Terasawa E; Kuznik A; Chen Z; Bégo-Le Bagousse G; Lu Y; Rizova E; Graham NMH; Pirozzi G; De Bruin-Weller M; Eckert L
    Acta Derm Venereol; 2019 Sep; 99(10):851-857. PubMed ID: 31099402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
    Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Rini GB; Corrocher R
    Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug survival and postdrug survival of first-line immunosuppressive treatments for atopic dermatitis: comparison between methotrexate and cyclosporine.
    Law Ping Man S; Bouzillé G; Beneton N; Safa G; Dupuy A; Droitcourt C
    J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1327-1335. PubMed ID: 29444359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with intravenous immunoglobulin in severe childhood atopic dermatitis.
    Ozen A; Baris S; Karakoc Aydiner E; Yucelten D; Nadir Bahceciler N
    Allergol Immunopathol (Madr); 2012; 40(2):131-3. PubMed ID: 21855202
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-Dose Cyclosporine A in the Treatment of Severe Atopic Dermatitis Complicated by Chronic Hepatitis C Virus Infection.
    Gnarra M; De Simone C; Garcovich M; Garcovich S
    Pediatr Dermatol; 2017 May; 34(3):374-376. PubMed ID: 28382768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with cyclosporin A.
    Thijs JL; Drylewicz J; Bruijnzeel-Koomen CAFM; Giovannone B; Knol EF; de Bruin-Weller MS; Nierkens S; Hijnen D
    Allergy; 2019 Mar; 74(3):613-617. PubMed ID: 30368864
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclosporin in atopic dermatitis: review of the literature and outline of a Belgian consensus.
    Naeyaert JM; Lachapelle JM; Degreef H; de la Brassinne M; Heenen M; Lambert J
    Dermatology; 1999; 198(2):145-52. PubMed ID: 10325461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractory atopic dermatitis treated with low dose cyclosporin.
    Yu FC; Gibbon GW; Klaustermeyer WB
    Ann Allergy Asthma Immunol; 2002 Aug; 89(2):127-31. PubMed ID: 12197567
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclosporin for atopic dermatitis in children.
    Harper JI; Berth-Jones J; Camp RD; Dillon MJ; Finlay AY; Holden CA; O'Sullivan D; Veys PA
    Dermatology; 2001; 203(1):3-6. PubMed ID: 11549791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Use of Systemic Treatments for Moderate-to-Severe Atopic Dermatitis in Adults: A Monocentric Retrospective Study.
    Védie AL; Ezzedine K; Amazan E; Boralevi F; Milpied B; Taïeb A; Seneschal J
    Acta Derm Venereol; 2016 Aug; 96(6):802-6. PubMed ID: 26925822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine in severe childhood atopic dermatitis: a multicenter study.
    Berth-Jones J; Finlay AY; Zaki I; Tan B; Goodyear H; Lewis-Jones S; Cork MJ; Bleehen SS; Salek MS; Allen BR; Smith S; Graham-Brown RA
    J Am Acad Dermatol; 1996 Jun; 34(6):1016-21. PubMed ID: 8647967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum creatinine levels during and after long-term treatment with cyclosporine A in patients with severe atopic dermatitis.
    van der Schaft J; van Zuilen AD; Deinum J; Bruijnzeel-Koomen CA; de Bruin-Weller MS
    Acta Derm Venereol; 2015 Nov; 95(8):963-7. PubMed ID: 25916428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis.
    Berth-Jones J; Graham-Brown RA; Marks R; Camp RD; English JS; Freeman K; Holden CA; Rogers SC; Oliwiecki S; Friedmann PS; Lewis-Jones MS; Archer CB; Adriaans B; Douglas WS; Allen BR
    Br J Dermatol; 1997 Jan; 136(1):76-81. PubMed ID: 9039299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring trough levels in cyclosporine for atopic dermatitis: A systematic review.
    Blake SC; Murrell DF
    Pediatr Dermatol; 2019 Nov; 36(6):843-853. PubMed ID: 31566785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two formulations of cyclosporin A in the treatment of severe atopic dermatitis. Aa double-blind, single-centre, cross-over pilot study.
    Zurbriggen B; Wüthrich B; Cachelin AB; Wili PB; Kägi MK
    Dermatology; 1999; 198(1):56-60. PubMed ID: 10026403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of severe refractory adult atopic dermatitis with ustekinumab.
    Puya R; Alvarez-López M; Velez A; Casas Asuncion E; Moreno JC
    Int J Dermatol; 2012 Jan; 51(1):115-6. PubMed ID: 22182388
    [No Abstract]   [Full Text] [Related]  

  • 19. First experience with extended release tacrolimus in the treatment of adult patients with severe, difficult to treat atopic dermatitis: Clinical efficacy, safety and dose finding.
    van der Schaft J; van Schaik RH; van Zuilen AD; Hijnen DJ; Berg MT; van den Broek MP; Bruijnzeel-Koomen CA; de Bruin-Weller MS
    J Dermatol Sci; 2016 Jan; 81(1):66-8. PubMed ID: 26547110
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral Cyclosporine Weekend Therapy: A New Maintenance Therapeutic Option in Patients with Severe Atopic Dermatitis.
    Garrido Colmenero C; Blasco Morente G; Tercedor Sánchez J
    Pediatr Dermatol; 2015; 32(4):551-2. PubMed ID: 25939958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.